نتائج البحث - "Alsaleh, Abdul Jabbar Omar"

1

دورية أكاديمية

An exploratory analysis of the cost‐effectiveness of insulin glargine 300 units/mL versus insulin glargine 100 units/mL over a lifetime horizon using the BRAVO diabetes model

المؤلفون: Shao, Hui, Shi, Lizheng, Fonseca, Vivian, Alsaleh, Abdul Jabbar Omar, Gill, Jasvinder, Nicholls, Charlie

المساهمون: Sanofi

المصدر: Diabetic Medicine ; volume 41, issue 5 ; ISSN 0742-3071 1464-5491

الإتاحة: https://doi.org/10.1111/dme.15303Test

View record in BASE

2

دورية أكاديمية

Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in Patients with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the UK

المؤلفون: McCrimmon, Rory J., Palmer, Karen, Alsaleh, Abdul Jabbar Omar, Lew, Elisheva, Puttanna, Amar

المصدر: McCrimmon , R J , Palmer , K , Alsaleh , A J O , Lew , E & Puttanna , A 2022 , ' Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in Patients with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the UK ' , Diabetes Therapy , vol. 13 , pp. 1203-1214 . https://doi.org/10.1007/s13300-022-01267-3Test

مصطلحات موضوعية: BIAsp 30, Cost-effectiveness, Cost-utility, iGlarLixi, Premix, SoliMix, Type 2 diabetes, United Kingdom, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, name=Endocrinology, Diabetes and Metabolism

وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document

العلاقة: https://discovery.dundee.ac.uk/en/publications/dbef844f-c2fb-4f84-a40a-0c92c3f8893cTest

الإتاحة: https://doi.org/10.1007/s13300-022-01267-3Test
https://discovery.dundee.ac.uk/en/publications/dbef844f-c2fb-4f84-a40a-0c92c3f8893cTest
https://discovery.dundee.ac.uk/ws/files/74382595/McCrimmon2022_Article_Cost_EffectivenessOfIGlarLixiV.pdfTest
https://discovery.dundee.ac.uk/ws/files/74382599/McCrimmon_SoliMix_UK_CEA_ms_Diabet_Ther_SUPP_REV_12Apr22.docxTest
http://www.scopus.com/inward/record.url?scp=85129875188&partnerID=8YFLogxKTest

View record in BASE

3

دورية أكاديمية

Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in People with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the US

المؤلفون: Shao, Hui, Alsaleh, Abdul Jabbar Omar, Dex, Terry, Lew, Elisheva, Fonseca, Vivian

المساهمون: Sanofi, France

المصدر: Diabetes Therapy ; volume 13, issue 9, page 1659-1670 ; ISSN 1869-6953 1869-6961

مصطلحات موضوعية: Endocrinology, Diabetes and Metabolism, Internal Medicine

الإتاحة: https://doi.org/10.1007/s13300-022-01300-5Test

View record in BASE

4

دورية أكاديمية

Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK

المؤلفون: McCrimmon, Rory J., Falla, Edel, Sha, Jo Zhou, Alsaleh, Abdul Jabbar Omar, Lew, Elisheva, Hudson, Richard, Baxter, Mike, Palmer, Karen

المصدر: McCrimmon , R J , Falla , E , Sha , J Z , Alsaleh , A J O , Lew , E , Hudson , R , Baxter , M & Palmer , K 2021 , ' Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK ' , Diabetes Therapy , vol. 12 , no. 12 , pp. 3217-3230 . https://doi.org/10.1007/s13300-021-01159-yTest

مصطلحات موضوعية: Cost-effectiveness, Cost-utility, Dulaglutide, GLP-1 receptor agonist, iDegLira, iGlarLixi, Liraglutide, Type 2 diabetes mellitus, United Kingdom, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, name=Endocrinology, Diabetes and Metabolism

وصف الملف: application/pdf

العلاقة: https://discovery.dundee.ac.uk/en/publications/9b18fb92-4700-472e-a7bd-cf9fda7c907eTest

الإتاحة: https://doi.org/10.1007/s13300-021-01159-yTest
https://discovery.dundee.ac.uk/en/publications/9b18fb92-4700-472e-a7bd-cf9fda7c907eTest
https://discovery.dundee.ac.uk/ws/files/68966155/McCrimmon2021_Article_Cost_EffectivenessOfIGlarLixiI.pdfTest
http://www.scopus.com/inward/record.url?scp=85118320249&partnerID=8YFLogxKTest

View record in BASE

5

دورية أكاديمية

Cost-Effectiveness of iGlarLixi Versus iDegLira in Type 2 Diabetes Mellitus Inadequately Controlled by GLP-1 Receptor Agonists and Oral Antihyperglycemic Therapy

المؤلفون: McCrimmon, Rory J., Lamotte, Mark, Ramos, Mafalda, Alsaleh, Abdul Jabbar Omar, Souhami, Elisabeth, Lew, Elisheva

المصدر: McCrimmon , R J , Lamotte , M , Ramos , M , Alsaleh , A J O , Souhami , E & Lew , E 2021 , ' Cost-Effectiveness of iGlarLixi Versus iDegLira in Type 2 Diabetes Mellitus Inadequately Controlled by GLP-1 Receptor Agonists and Oral Antihyperglycemic Therapy ' , Diabetes Therapy , vol. 12 , no. 12 , pp. 3231-3241 . https://doi.org/10.1007/s13300-021-01156-1Test

مصطلحات موضوعية: Cost-effectiveness, Cost-utility, GLP-1 receptor agonist, iGlarLixi, Type 2 diabetes mellitus, United Kingdom, /dk/atira/pure/subjectarea/asjc/2700/2724, name=Internal Medicine, /dk/atira/pure/subjectarea/asjc/2700/2712, name=Endocrinology, Diabetes and Metabolism